CIDRAP newsletters options
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Apr 1
A new report from antibiotic research and development (R&D) advocacy group ReAct outlines the challenges and solutions for creating a new model that will deliver sustainable access to antibiotics for all countries.
Respiratory and heart disease are some of the problems plaguing COVID patients after more than 4 months.
The WHO repeats a call for 10 million vaccine doses for nations that haven't reached vulnerable groups.
The vaccine was also 100% effective in South Africa, where the highly transmissible B1351 variant is dominant.
The first global assessment of the collateral impact of the COVID-19 pandemic on pregnancy outcomes found a significant increase in stillbirths, maternal deaths, maternal depression, and women requiring surgery for ectopic pregnancy, researchers reported yesterday in The Lancet Global Health.
The vaccine was 70.4% effective against symptomatic B117 and 81.5% against other strains.
Also, the WHO says ivermectin should be used only to treat COVID-19 within clinical trials.
The vaccine was 100% effective in a phase 3 US trial involving 2,260 adolescents 12 to 15 years old.
Racial and ethnic differences in intention to receive a COVID-19 vaccine were comparable across both healthcare workers (HCWs) and the general public in the San Francisco Bay area this winter, according to survey results published yesterday in JAMA Internal Medicine.
The UK and South Korea report fewer primary care, emergency visits, 3 studies say.
"The failure to take this virus seriously is precisely what got us into this mess in the first place."
Experts say a jump from an intermediate animal carrier is the likeliest scenario.
An analysis of neighborhood-level data in three US cities highlights the racial and socioeconomic disparities in COVID-19 positivity, incidence, and mortality, researchers reported today in the Annals of Internal Medicine.
"We can win this by hanging in there a bit longer," medical adviser Anthony Fauci says.
Antibodies from both recovered and vaccinated people neutralized the UK variant better than the South African one.
Also, Brazilian researchers warned of a link between the P1 variant and higher death rates in younger adults.
Adults 20 to 49 years old may be sustaining the resurgence of COVID-19, according to a study published late last week in Science.
The results of a randomized clinical trial conducted in France indicate that 3 days of beta-lactam therapy is non-inferior to 8 days of treatment in patients hospitalized with community-acquired pneumonia who meet clinical stability criteria after 3 days, French investigators reported last week in The Lancet Infectious Diseases.
Antibody response was akin to that in non-pregnant women, with a similar safety profile.
